CEL-SCI Corporation news

   Watch this stock
Showing stories 1 - 10 of about 10   

Articles published

CVM 1.96 +0.06 (3.16%)
price chart
CEL-SCI Announces Update on Ongoing Arbitration against Former Clinical ...
On October 3, 2017, Lake Whillans Litigation Funding and CEL-SCI agreed to give an incentive to the law firm, Wilk Auslander, which is handling the case for CEL-SCI against the former CRO. Pursuant to this new arrangement, Lake Whillans has agreed to ...
CEL-SCI Granted European Patent for Multikine's Mechanism of Action in Making ...
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) announced today that the European Patent Office has issued a new patent to CEL-SCI for its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), which ...
The Fundamental Case for and Against CEL-SCI Corporation (CVM)  StockNewsGazette
Cel-Sci says arbitration with inVentiv nearing an end
The arbitration relates to a Phase III trial of Cel-Sci's candidate immunotherapy Multikine (Leukocyte Interleukin, Injection) in the treatment of patients suffering squamous cell carcinoma of the head and neck.
Tracking the one year Price Target on CEL-SCI Corporation (CVM)
Cel-Sci Corporation (NYSEMKT:CVM) stock ended the last trade transaction at $1.71. The 50-Day Moving Average price noticed at $1.79 and the 200 Day Moving Average price is at $1.21.
Did Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Trigger A Hold Signal?
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) gained 4.36% in yesterday's session, going up from its prior closing price of $50.70 to $52.91.
Rennova Health, Inc. (RNVA) closed the last trading session at $0.17
Insider Trading is buying and selling of a security by a person who has access to material information related to a security that is not available to general public.
What the Insider Data Suggests About ZIOPHARM Oncology, Inc. (ZIOP)
Recent insider trends for ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) have caught the attention of investors. Analysts monitor insider data to understand the sentiment of a company's largest and most important shareholders.
Hot On The Charts: KalVista Pharmaceuticals, Inc. (KALV), Sage Therapeutics ...
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) traded at an unexpectedly high level on 11/10/2017 when the stock experienced a -1.86% loss to a closing price of $10.
DR Horton Inc. (DHI) has a market cap of $14.71 Billion
DR Horton Inc. (DHI) shares jumped and closed the day at $40.27, with the percent change of 0.73%. The company has its outstanding shares of 365.38 Million.
Gastar Exploration Inc. (GST) has its outstanding shares of 216.7 Million
Gastar Exploration Inc. (GST) shares fell and closed the day at $0.82, with the percent change of -3.72%. The company has its outstanding shares of 216.7 Million.